Exeliom Biosciences
Paris, FR · Founded 2016 · 10 employees on LinkedIn · 3 known investors
Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis). The company's projects have been supported by public and non-profit funding programs.
Founders & leadership
Exeliom Biosciences was founded in 2016 by Harry Sokol.
HS
Harry SokolScientific Co-founder
Investors · 3
Frequently asked questions
- What does Exeliom Biosciences do?
- Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis). The company's projects have been supported by public and non-profit funding programs.
- Who founded Exeliom Biosciences?
- Exeliom Biosciences was founded by Harry Sokol in 2016.
- Who are Exeliom Biosciences's investors?
- Exeliom Biosciences's investors include Bpifrance, Agoranov, Forepont Capital Partners.
- Where is Exeliom Biosciences headquartered?
- Exeliom Biosciences is headquartered in Paris, FR.